{
    "ticker": "PETV",
    "name": "PetVivo Holdings, Inc.",
    "description": "PetVivo Holdings, Inc. is an emerging biotechnology company focused on the development and commercialization of innovative products for the veterinary market. Founded in 2016 and headquartered in Minneapolis, Minnesota, PetVivo is dedicated to improving the quality of life for animals through advanced medical technologies. The company's flagship product, Kvet, is a novel therapeutic device designed to treat osteoarthritis and other joint-related conditions in dogs and cats. Kvet utilizes a proprietary, injectable polymer that mimics the natural synovial fluid found in healthy joints, helping to alleviate pain and improve mobility in affected animals. PetVivo's mission is to provide veterinarians with superior solutions to enhance animal health and wellness. The company is actively engaged in research and clinical studies to expand its product offerings and ensure that its therapies are safe and effective. As a forward-thinking organization, PetVivo is committed to leveraging cutting-edge scientific advancements to develop therapies that address unmet needs in the veterinary space. With a growing portfolio of intellectual property and a focus on collaboration with veterinary professionals, PetVivo aims to establish itself as a leader in the animal health market.",
    "industry": [
        "Biotechnology",
        "Veterinary Medicine"
    ],
    "headquarters": "Minneapolis, Minnesota, USA",
    "founded": "2016",
    "website": "https://www.petvivo.com",
    "ceo": "John Lai",
    "social_media": {
        "twitter": "https://twitter.com/PetVivo",
        "linkedin": "https://www.linkedin.com/company/petvivo-holdings-inc/"
    },
    "investor_relations": "https://www.petvivo.com/investor-relations/",
    "key_executives": [
        {
            "name": "John Lai",
            "position": "CEO"
        },
        {
            "name": "Richard T. Hargreaves",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Veterinary Therapeutics",
            "products": [
                "Kvet"
            ]
        }
    ],
    "seo": {
        "meta_title": "PetVivo Holdings, Inc. | Innovative Veterinary Solutions",
        "meta_description": "Explore PetVivo Holdings, Inc., a biotechnology company dedicated to advancing veterinary medicine with innovative products like Kvet for joint health in animals.",
        "keywords": [
            "PetVivo",
            "Veterinary Medicine",
            "Biotechnology",
            "Animal Health",
            "Kvet",
            "Osteoarthritis Treatment"
        ]
    },
    "faq": [
        {
            "question": "What is PetVivo Holdings known for?",
            "answer": "PetVivo Holdings is known for developing innovative veterinary therapeutics, particularly Kvet, an injectable treatment for joint conditions in pets."
        },
        {
            "question": "Who is the CEO of PetVivo?",
            "answer": "John Lai is the CEO of PetVivo Holdings, Inc."
        },
        {
            "question": "Where is PetVivo headquartered?",
            "answer": "PetVivo is headquartered in Minneapolis, Minnesota, USA."
        },
        {
            "question": "What products does PetVivo offer?",
            "answer": "PetVivo's main product is Kvet, designed for treating osteoarthritis in pets."
        },
        {
            "question": "When was PetVivo founded?",
            "answer": "PetVivo was founded in 2016."
        }
    ],
    "competitors": [
        "ZTS",
        "IDXX",
        "PRAN"
    ],
    "related_stocks": [
        "AMZN",
        "AAPL",
        "GOOGL",
        "MSFT"
    ]
}